AXSOME THERAPEUTICS INC's ticker is AXSM and the CUSIP is 05464T104. A total of 178 filers reported holding AXSOME THERAPEUTICS INC in Q2 2021. The put-call ratio across all filers is 1.98 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $648,789 | -7.7% | 9,283 | -5.1% | 0.01% | 0.0% |
| Q2 2023 | $702,647 | +20.7% | 9,778 | +3.6% | 0.01% | +20.0% |
| Q1 2023 | $582,074 | -11.5% | 9,437 | +10.6% | 0.01% | -16.7% |
| Q4 2022 | $657,842 | +85.8% | 8,529 | +7.5% | 0.01% | +50.0% |
| Q3 2022 | $354,000 | +20.8% | 7,931 | +3.5% | 0.00% | +33.3% |
| Q2 2022 | $293,000 | +6.9% | 7,661 | +15.7% | 0.00% | +50.0% |
| Q1 2022 | $274,000 | +10.0% | 6,623 | +0.5% | 0.00% | 0.0% |
| Q4 2021 | $249,000 | +13.7% | 6,592 | -0.9% | 0.00% | 0.0% |
| Q3 2021 | $219,000 | -50.8% | 6,652 | +0.8% | 0.00% | -50.0% |
| Q2 2021 | $445,000 | -3.7% | 6,598 | -19.1% | 0.00% | 0.0% |
| Q1 2021 | $462,000 | -30.1% | 8,153 | +0.5% | 0.00% | -33.3% |
| Q4 2020 | $661,000 | +10.5% | 8,109 | -3.4% | 0.01% | 0.0% |
| Q3 2020 | $598,000 | +16.3% | 8,391 | +34.2% | 0.01% | -14.3% |
| Q2 2020 | $514,000 | +53.9% | 6,252 | +10.2% | 0.01% | +16.7% |
| Q1 2020 | $334,000 | – | 5,671 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ALETHEA CAPITAL MANAGEMENT, LLC | 758,794 | $53,032,113 | 65.14% |
| Fairmount Funds Management LLC | 2,341,238 | $163,629,124 | 19.69% |
| Ally Bridge Group (NY) LLC | 110,600 | $7,729,834 | 9.07% |
| RTW INVESTMENTS, LP | 4,489,596 | $313,777,864 | 6.62% |
| SVB FINANCIAL GROUP | 33,849 | $2,365,707 | 4.45% |
| BVF INC/IL | 2,131,100 | $148,942,579 | 4.02% |
| Altium Capital Management LP | 92,000 | $6,429,880 | 3.35% |
| Tri Locum Partners LP | 142,510 | $9,960,024 | 3.18% |
| TANG CAPITAL MANAGEMENT LLC | 320,000 | $22,364,800 | 3.16% |
| Deep Track Capital, LP | 1,140,745 | $79,726,668 | 3.08% |